CVE-2025-32631

CVE-2025-32631 is a high-severity vulnerability with a CVSS 3.x base score of 8.6. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-22.

Key facts

Description

Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') vulnerability in oxygensuite Oxygen MyData for WooCommerce oxygen-mydata allows Path Traversal.This issue affects Oxygen MyData for WooCommerce: from n/a through <= 1.0.64.

Frequently asked questions

What is CVE-2025-32631?
Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') vulnerability in oxygensuite Oxygen MyData for WooCommerce oxygen-mydata allows Path Traversal.This issue affects Oxygen MyData for WooCommerce: from n/a through <= 1.0.64.
How severe is CVE-2025-32631?
CVE-2025-32631 has a CVSS 3.x base score of 8.6, rated high severity. It is exploitable over network with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is none, integrity none, and availability high.
Is CVE-2025-32631 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (49th percentile), an estimate of the probability of exploitation in the next 30 days.
How do I fix CVE-2025-32631?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.
Does CVE-2025-32631 have an EU (EUVD) identifier?
Yes. CVE-2025-32631 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2025-10743.
When was CVE-2025-32631 published?
CVE-2025-32631 was published on 2025-04-11 and last updated on 2026-06-17.

References

Other CWE-22 (Path Traversal) vulnerabilities

Browse all CWE-22 (Path Traversal) vulnerabilities →